港股異動 | 中國玻璃(3300.HK)大幅反彈超12% 此前曾回撤近40%
格隆匯9月21日丨中國玻璃(3300.HK)尾盤大幅拉昇反彈12.45%,此前最大回撤近40%。現報3.07港元,暫成交3575萬港元,總市值56億港元。公司是中國領先的平板玻璃和鍍膜玻璃生產商,以浮法玻璃為主業。西部證券日前指出,公司產能在行業高景氣階段投放,有望享受價格方面的優勢,支撐公司業績彈性。同時,“三道紅線”也強化地產商加快竣工和結轉的邏輯,當下極低的庫存和金九銀十的傳統旺季將支撐玻璃後期走勢。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.